Soluble FcεRI is a potential biomarker for therapeutic response to omalizumab in patients with chronic spontaneous urticaria

被引：0
作者：
Moino-Romero, S. [1 ,2 ,3 ]
Kolkhir, P. [1 ,2 ,4 ]
Szepfalusi, Z. [3 ]
Hawro, T. [1 ,2 ]
Weller, K. [1 ,2 ]
Metz, M. [1 ,2 ]
Maurer, M. [1 ,2 ]
Altrichter, S. [1 ,2 ]
机构：
[1] Charite Univ Med Berlin, Dept Dermatol & Allergy, Allergie Ctr Charite, Dermatol Allergol, Berlin, Germany
[2] Humboldt Univ, Freie Univ Berlin, Berlin, Germany
[3] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria
[4] IM Sechenov First Moscow State Med Univ Sechenov, Div Immune Mediated Skin Dis, Moscow, Russia
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P070
引用
收藏
页码：E36 / E36
页数：1
相关论文
共 50 条
  • [11] Predictors of response to omalizumab in chronic spontaneous urticaria
    Du, Zhirong
    Zhi, Yuxiang
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB208 - AB208
  • [12] Predictors of omalizumab response in chronic spontaneous urticaria
    Marcelino, J.
    Costa, A. C.
    Aguiar, P.
    Pereira Barbosa, M.
    [J]. ALLERGY, 2016, 71 : 186 - 186
  • [13] Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin
    Metz, Martin
    Staubach, Petra
    Bauer, Andrea
    Brehler, Randolf
    Gericke, Janine
    Kangas, Michael
    Ashton-Chess, Joanna
    Jarvis, Philip
    Georgiou, Panayiotis
    Canvin, Janice
    Hillenbrand, Rainer
    Erpenbeck, Veit J.
    Maurer, Marcus
    [J]. THERANOSTICS, 2017, 7 (05): : 1266 - 1276
  • [14] Is There a Difference in Omalizumab Treatment Response in Patients With Chronic Autoimmune Urticaria vs Chronic Spontaneous Urticaria?
    Khalsa, Kiranjit K.
    Patel, Gargi
    Testo, Natalia
    Pasha, Muhammad A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB57 - AB57
  • [15] Total IgE as a biomarker of omalizumab response in chronic spontaneous urticaria: A meta-analysis
    Keller, Levi
    Perera, Ekta K.
    Bindon, Brittany
    Khatiwada, Aastha
    Stitt, Jenny M.
    Dreskin, Stephen C.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2024, 45 (02) : 97 - 99
  • [16] Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria
    Marta Ferrer
    Isabelle Boccon-Gibod
    Margarida Gonçalo
    Hüseyin Serhat İnalöz
    André Knulst
    Hilde Lapeere
    Anchala Parthasaradhi
    Georg Stingl
    Anna Tagka
    Fernando Valenzuela
    Jensen Yeung
    Simon Francis Thomsen
    [J]. European Journal of Dermatology, 2017, 27 : 455 - 463
  • [17] Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria
    Kaplan, Allen
    Ferrer, Marta
    Bernstein, Jonathan A.
    Antonova, Evgeniya
    Trzaskoma, Benjamin
    Raimundo, Karina
    Rosen, Karin
    Omachi, Theodore A.
    Khalil, Sam
    Zazzali, James L.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : 474 - 481
  • [18] Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?
    Casale, Thomas B.
    Trzaskoma, Benjamin
    Holden, Michael
    Bernstein, Jonathan A.
    Maurer, Marcus
    [J]. WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (08):
  • [19] TIME TO CLINICALLY MEANINGFUL RESPONSE TO OMALIZUMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA
    Casale, T.
    Holden, M.
    Trzaskoma, B.
    Bernstein, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S26 - S27
  • [20] Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria
    Ferrer, Marta
    Boccon-Gibod, Isabelle
    Goncalo, Margarida
    Inaloz, Huseyin Serhat
    Knulst, Andre
    Lapeere, Hilde
    Parthasaradhi, Anchala
    Stingl, Georg
    Tagka, Anna
    Valenzuela, Fernando
    Yeung, Jensen
    Thomsen, Simon Francis
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (05) : 455 - 463
12345